The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study
Open accessAbstract
BACKGROUND: Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) are a common cause of hospital admission. Many exacerbations are believed to be due to upper and/or lower respiratory tract viral infections, but the incidence of these infections in patients with COPD is still undetermined. METHODS: Respiratory syncytial virus (RSV), influenza A and B, parainfluenza 3, and picornaviruses were detected by nested reverse transcription polymerase chain reaction (RT-PCR) in upper (nasal lavage) and lower respiratory tract specimens (induced sputum). In a 2:1 case-control set up, 85 hospitalised patients with AE-COPD and 42 patients with stable COPD admitted for other medical reasons were studied. RESULTS: Respiratory viruses were found more often in sputum and nasal lavage of patients with AE-COPD (48/85, 56%) than in patients with stable COPD (8/42, 19%, p<0.01). The most common viruses were picornaviruses (21/59, 36%), influenza A (15/59, 25%), and RSV (13/59, 22%). When specimens were analysed separately, this difference was seen in induced sputum (exacerbation 40/85 (47%) v stable 4/42 (10%), p<0.01) but was not significant in nasal lavage (exacerbation 26/85 (31%) v stable 7/42 (17%), p=0.14). In patients with AE-COPD, fever was more frequent in those in whom viruses were detected (12/48, 25%) than in those in whom viruses were not detected (2/37, 5%, p=0.03). CONCLUSION: Viral respiratory pathogens are found more often in respiratory specimens of hospitalised patients with AE-COPD than in control patients. Induced sputum detects respiratory viruses more frequently than nasal lavage in these patients. These data indicate that nasal lavage probably has no additional diagnostic value to induced sputum in cross-sectional studies on hospitalised patients with AE-COPD and that the role of viral infection in these patients is still underestimated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
(1993) · PubMed · Cited by 3,827
Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease
Celli, B. R., Snider, G. L., Heffner, J. E., Tiep, B. L., Ziment, I., Make, B. J., Braman, S. S., Olsen, G. N., & D, Y. Y. P. M. (1995) · Cited by 3,506
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Respiratory viruses and exacerbations of asthma in adults
Nicholson, K. G., Kent, J., & Ireland, D. C. (1993) · BMJ · doi:10.1136/bmj.307.6910.982 · Cited by 1,127
Cited by
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
“25, 26 Molecular diagnostic techniques have now enabled detection of respiratory viruses at exacerbation, which have been isolated in around half of exacerbations, 27, 28 although this fi nding might be an underestimate due to diffi culties in sampling at onset of symptoms.”
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sethi, S., & Murphy, T. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800353 · Cited by 1,234
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
“Independently, both bacterial (5, 6) and viral infections (7, 8) have been detected at increased frequencies during exacerbations, and acquisition of new bacterial strains is associated with increased risk of exacerbation (9).”
BackgroundGuidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Jacobs, S. E., Lamson, D. M., St. George, K., & Walsh, T. J. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-12 · Cited by 704
Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease
Wilkinson, T. M. A., Donaldson, G. C., Hurst, J. R., Seemungal, T. A. R., & Wedzicha, J. A. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1443oc · Cited by 693
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Air Pollution and Respiratory Viral Infection
Ciencewicki, J., & Jaspers, I. (2007) · Inhalation Toxicology · doi:10.1080/08958370701665434 · Cited by 488
“Besides causing morbidity and 1135 mortality in otherwise healthy individuals, respiratory virus infections are also thought to be a major cause for exacerbations of chronic lung diseases, such as asthma and COPD (Johnston et al., 1995; Nicholson et al., 1993; Rhode et al., 2003; Seemungal et al., 2000; Seemungal et a…”
BackgroundInfluentialGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Complications of Viral Influenza
Rothberg, M. B., Haessler, S. D., & Brown, R. B. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.040 · Cited by 456
“42 Mechanisms by which influenza virus and other respiratory viruses induce exacerbations of chronic respiratory diseases are incompletely understood but are likely related to inflammatory mediators, including interleukins, cytokines, and modifications in the ratio of T-cell subsets that lead to increased sensitivity…”
BackgroundExacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00160-0 · Cited by 416
Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
Ritchie, A. I., & Wedzicha, J. A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.007 · Cited by 402
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362
The disease burden of influenza beyond respiratory illness
Macias, A. E., McElhaney, J. E., Chaves, S. S., Nealon, J., Nunes, M. C., Samson, S. I., Seet, B. T., Weinke, T., & Yu, H. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.09.048 · Cited by 371
Singh, S., Amin, A. V., & Loke, Y. K. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.550 · Cited by 346
Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
Byers, D. E., Alexander-Brett, J., Patel, A. C., Agapov, E., Dang-Vu, G., Jin, X., Wu, K., You, Y., Alevy, Y., Girard, J.-P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65570 · Cited by 337
Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2006) · Chest · doi:10.1378/chest.129.2.317 · Cited by 317
Viniol, C., & Vogelmeier, C. F. (2018) · European Respiratory Review · doi:10.1183/16000617.0103-2017 · Cited by 283
Exacerbations of Chronic Obstructive Pulmonary Disease
(2016) · Respiratory Infections · doi:10.3109/9781420080353-7 · Cited by 270
The ABCs of Rhinoviruses, Wheezing, and Asthma
Gern, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.02290-09 · Cited by 263
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Wedzicha, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306030 · Cited by 261
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Bozinovski, S., Hutchinson, A., Thompson, M., MacGregor, L., Black, J., Giannakis, E., Karlsson, A.-S., Silvestrini, R., Smallwood, D., Vlahos, R., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-678oc · Cited by 260
“Respiratory viral infection and the acquisition of a new bacterial strain have both been characterized in AECOPD (11, 12).”
BackgroundBaldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., & Persing, D. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1129 · Cited by 256
Sajjan, U. S., Jia, Y., Newcomb, D. C., Bentley, J. K., Lukacs, N. W., LiPuma, J. J., Hershenson, M. B., Sajjan, U. S., Jia, Y., Newcomb, D. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5806fje · Cited by 146
Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations
De Serres, G., Lampron, N., La Forge, J., Rouleau, I., Bourbeau, J., Weiss, K., Barret, B., & Boivin, G. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.07.010 · Cited by 108
Avadhanula, V., Wang, Y., Portner, A., & Adderson, E. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47086-0 · Cited by 91
“…NTHi and S. pneumoniae have been isolated more commonly and in larger numbers from patients with antecedent RSV infections than from patients without RSV infection, suggesting that viral infection increases bacterial colonization (Avadhanula et al., 2006a; Rohde et al., 2003; Smith et al., 1976).”
BackgroundBellinghausen, C., Gulraiz, F., Heinzmann, A. C. A., Dentener, M. A., Savelkoul, P. H. M., Wouters, E. F., Rohde, G. G., & Stassen, F. R. (2016) · Respiratory Research · doi:10.1186/s12931-016-0382-z · Cited by 71
Self-citation
Metadata
- Authors
- Rohde, G.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2003-01-01
- Volume
- 58
- Issue
- 1
- Pages
- 37-42
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2112692443
- Cited by
- 524
- References
- 33
- FWCI
- 26.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.